Jupiter Life Line Hospitals Limited
NSE: JLHL BSE: JLHL
Prev Close
1448.8
Open Price
1469.9
Volume
23,013
Today Low / High
1425.2 / 1469.9
52 WK Low / High
1263.2 / 1770
Range
1,386 - 1,532
Prev Close
1447.5
Open Price
1448.1
Volume
850
Today Low / High
1430 / 1462.8
52 WK Low / High
1250 / 1759
Range
1,387 - 1,533
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1459 (target range: 1,386 - 1,532), reflecting a change of 10.2 (0.70403%). On the BSE, it is listed at 1460.3 (target range: 1,387 - 1,533), showing a change of 12.8 (0.88428%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Jupiter Life Line Hospitals Limited Graph
Jupiter Life Line Hospitals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Jupiter Life Line Hospitals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,459.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
Scenario | Price | Target | Range |
---|---|---|---|
Bullish Scenario | 1,460.30 | 1,474.90 | 1,327.41 - 1,622.39 |
1,489.51 | 1,191.60 - 1,787.41 | ||
1,504.11 | 1,052.88 - 1,955.34 | ||
Bearish Scenario | 1,460.30 | 1,445.70 | 1,301.13 - 1,590.27 |
1,431.09 | 1,144.88 - 1,717.31 | ||
1,416.49 | 991.54 - 1,841.44 |
Overview of Jupiter Life Line Hospitals Limited
ISIN
INE682M01012
Industry
Medical - Care Facilities
Vol.Avg
43,858
Market Cap
95,660,829,016
Last Dividend
1
Official Website
IPO Date
2023-09-18
DCF Diff
1,758.88
DCF
-300
Financial Ratios Every Investor Needs
Stock Dividend of JLHL
Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|---|
2025-07-04 | July 04, 25 | 1 | 1 | 2025-07-04 | 2025-08-10 | |
2024-08-02 | August 02, 24 | 1 | 1 | 2024-08-02 | 2024-09-08 |
Annual Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 1,261.55 Cr | 230.16 Cr | 1,031.38 Cr | 0.8176 | 0.00 Cr | 312.12 Cr | 239.58 Cr | 193.20 Cr | 29.47 | 325.24 Cr | 0.1531 |
2024-03-31 | 1,069.50 Cr | 214.01 Cr | 855.49 Cr | 0.7999 | 0.00 Cr | 271.62 Cr | 198.21 Cr | 176.61 Cr | 28.68 | 260.97 Cr | 0.1651 |
2023-03-31 | 892.54 Cr | 181.15 Cr | 711.39 Cr | 0.7970 | 0.00 Cr | 218.02 Cr | 163.81 Cr | 72.91 Cr | 11.12 | 206.01 Cr | 0.0817 |
2022-03-31 | 733.12 Cr | 325.90 Cr | 407.23 Cr | 0.5555 | 0.00 Cr | 173.21 Cr | 118.35 Cr | 51.13 Cr | 7.80 | 149.93 Cr | 0.0697 |
2021-03-31 | 486.16 Cr | 245.22 Cr | 240.95 Cr | 0.4956 | 0.00 Cr | 115.96 Cr | 39.07 Cr | -2.30 Cr | -0.35 | 63.76 Cr | -0.0047 |
Annual Financials Balance Sheet
Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 488.67 Cr | 1,904.89 Cr | 548.64 Cr | 1,356.2420 Cr | 393.15 Cr | -95.52 Cr | 24.10 Cr | 1,157.96 Cr | 0.00 Cr | 0.00 Cr | 1.42 Cr | 152.4310 Cr |
2024-03-31 | 301.25 Cr | 1,281.33 Cr | 112.59 Cr | 1,169.0380 Cr | 0.00 Cr | -301.25 Cr | 21.34 Cr | 789.51 Cr | 0.00 Cr | 0.00 Cr | 21.83 Cr | 105.7540 Cr |
2023-03-31 | 134.46 Cr | 985.53 Cr | 621.62 Cr | 365.6850 Cr | 468.63 Cr | 334.16 Cr | 19.00 Cr | 748.10 Cr | 0.00 Cr | 0.00 Cr | 17.69 Cr | 132.1370 Cr |
2022-03-31 | 103.37 Cr | 908.70 Cr | 620.26 Cr | 293.5540 Cr | 495.25 Cr | 391.88 Cr | 15.36 Cr | 709.70 Cr | 0.00 Cr | 0.00 Cr | 4.22 Cr | 123.2040 Cr |
2021-03-31 | 19.44 Cr | 788.91 Cr | 542.46 Cr | 238.9760 Cr | 425.52 Cr | 406.08 Cr | 14.30 Cr | 655.36 Cr | 4.47 Cr | 0.00 Cr | -3.21 Cr | 95.8520 Cr |
Annual Financials Cash Flow Statement
Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 253.3040 Cr | -208.6240 Cr | 300.6280 Cr | -67.4220 Cr | 345.3080 Cr | 368.3190 Cr | -320.7260 Cr | 257.7010 Cr | 325.7130 Cr | -6.5570 Cr | -2.7570 Cr |
2024-03-31 | 114.5210 Cr | -75.8890 Cr | 128.1560 Cr | 29.2260 Cr | 166.7880 Cr | 301.2510 Cr | -85.2950 Cr | 176.6120 Cr | -472.4780 Cr | -5.6520 Cr | -2.3410 Cr |
2023-03-31 | 117.1670 Cr | -103.5700 Cr | 17.5000 Cr | 39.9240 Cr | 31.0980 Cr | 134.4630 Cr | -77.2430 Cr | 128.7080 Cr | 30.8800 Cr | -5.0870 Cr | -3.6450 Cr |
2022-03-31 | 136.9720 Cr | -85.2460 Cr | 32.2020 Cr | 45.2400 Cr | 84.9030 Cr | 103.3650 Cr | -91.7320 Cr | 77.1180 Cr | 87.8690 Cr | 0.0000 Cr | -2.3060 Cr |
2021-03-31 | 123.4067 Cr | -295.8470 Cr | 184.2900 Cr | -118.1820 Cr | 12.4640 Cr | 19.4380 Cr | -241.5890 Cr | 1.5550 Cr | 153.2760 Cr | 0.0000 Cr | 0.9190 Cr |
Quarterly Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|
2025-06-30 | 347.63 Cr | 68.36 Cr | 279.26 Cr | 0.8033 | 56.92 Cr | 43.84 Cr | 6.69 | 90.99 Cr | 0.1261 |
2025-03-31 | 331.20 Cr | 61.15 Cr | 270.06 Cr | 0.8154 | 65.10 Cr | 44.57 Cr | 6.84 | 85.28 Cr | 0.1346 |
2024-12-31 | 320.64 Cr | 58.80 Cr | 261.84 Cr | 0.8166 | 61.04 Cr | 52.51 Cr | 8.01 | 83.31 Cr | 0.1638 |
2024-09-30 | 322.58 Cr | 60.00 Cr | 262.58 Cr | 0.8140 | 60.59 Cr | 51.51 Cr | 7.86 | 84.43 Cr | 0.1597 |
2024-06-30 | 287.13 Cr | 50.22 Cr | 236.91 Cr | 0.8251 | 52.85 Cr | 44.61 Cr | 6.80 | 72.22 Cr | 0.1554 |
Quarterly Financials Balance Sheet
Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 488.67 Cr | 234.62 Cr | 602.93 Cr | 42.27 Cr | 24.10 Cr | 687.05 Cr | 1,157.96 Cr | 1,904.89 Cr | 548.64 Cr |
2024-12-31 | 0.00 Cr | 0.00 Cr | 329.10 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,258.29 Cr |
2024-09-30 | 245.83 Cr | 83.27 Cr | 329.10 Cr | 60.31 Cr | 24.23 Cr | 429.86 Cr | 883.28 Cr | 1,394.49 Cr | 136.20 Cr |
2024-06-30 | 0.00 Cr | 0.00 Cr | 318.12 Cr | 0.00 Cr | 0.00 Cr | 318.12 Cr | 0.00 Cr | 0.00 Cr | -1,168.74 Cr |
2024-03-31 | 301.25 Cr | 16.87 Cr | 318.12 Cr | 57.76 Cr | 21.34 Cr | 409.77 Cr | 789.51 Cr | 1,281.33 Cr | 112.59 Cr |
Quarterly Financials Cash Flow Statement
Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 44.87 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-12-31 | 52.51 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-09-30 | 51.51 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-06-30 | 44.61 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-03-31 | 45.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
Date | Label | Split Ratio |
---|---|---|
No split history data available. |
Similar Stocks: Medical - Care Facilities
Company Name | Symbol | Price | Market Cap | Volume |
---|---|---|---|---|
Max Healthcare Institute Limited | MAXHEALTH | ₹1,184.20 | ₹1,151,275,551,217.00 | ₹2,486,840.00 |
Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,874.50 | ₹1,132,234,982,500.00 | ₹117,760.00 |
Fortis Healthcare Limited | FORTIS | ₹970.00 | ₹732,309,260,000.00 | ₹835,817.00 |
Narayana Hrudayalaya Limited | NH | ₹1,764.30 | ₹360,554,112,300.00 | ₹219,399.00 |
Global Health Limited | MEDANTA | ₹1,322.30 | ₹355,314,015,162.00 | ₹243,343.00 |
Aster DM Healthcare Limited | ASTERDM | ₹632.05 | ₹327,478,378,050.00 | ₹595,597.00 |
Krishna Institute of Medical Sciences Limited | KIMS | ₹758.80 | ₹303,625,473,200.00 | ₹304,936.00 |
Rainbow Children's Medicare Limited | RAINBOW | ₹1,462.70 | ₹148,539,648,187.00 | ₹186,519.00 |
Jupiter Life Line Hospitals Limited | JLHL | ₹1,459.00 | ₹95,660,829,016.00 | ₹23,013.00 |
HealthCare Global Enterprises Limited | HCG | ₹678.40 | ₹94,579,136,000.00 | ₹308,400.00 |
Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹770.25 | ₹74,216,941,939.00 | ₹677,104.00 |
Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹489.65 | ₹44,887,684,450.00 | ₹226,991.00 |
Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Artemis Medicare Services Limited | ARTEMISMED | ₹239.15 | ₹33,217,935,000.00 | ₹118,361.00 |
Key Executives
Gender: female
Year Born:
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1955
Gender: male
Year Born:
Gender: female
Year Born:
Gender: male
Year Born:
Gender: Not Specified
Year Born:
Gender: Not Specified
Year Born: 1988
Gender: male
Year Born: 1971
Gender: Not Specified
Year Born:
FAQs about Jupiter Life Line Hospitals Limited
The CEO is Ankit Ajay Thakker.
The current price is ₹1,459.00.
The range is ₹1263.2-1770.
The market capitalization is ₹9,566.08 crores.
The dividend yield is 0.07%.
The P/E ratio is 49.68.
The company operates in the Healthcare sector.
Overview of Jupiter Life Line Hospitals Limited (ISIN: INE682M01012) is a leading Medical - Care Facilities in India. With a market capitalization of ₹9,566.08 crores and an average daily volume of 43,858 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹1.